This HTML5 document contains 198 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n9http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q47561313
rdf:type
wikibase:Item
schema:description
2017年学术文章 artigo científico teaduslik artikkel 2017年學術文章 artículu científicu 2017年学术文章 vědecký článek 2017年學術文章 บทความทางวิทยาศาสตร์ vetenskaplig artikel επιστημονικό άρθρο artigo científico 2017年学术文章 bài báo khoa học научни чланак artículo científico publicado en 2017 scientific article published on 22 December 2017 wissenschaftlicher Artikel artikel ilmiah 2017年學術文章 2017年学术文章 научная статья 2017년 논문 2017年学术文章 article scientific 2017年学术文章 2017年の論文 tieteellinen artikkeli artigo científico videnskabelig artikel artikulong pang-agham vedecký článok artykuł naukowy מאמר מדעי 2017年學術文章 articol științific vitskapeleg artikkel სამეცნიერო სტატია article científic ২২ ডিসেম্বর ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bilimsel makale tudományos cikk գիտական հոդված հրատարակված 2017 թվականի դեկտեմբերի 22-ին article scientifique vitenskapelig artikkel scientific article published on 22 December 2017 2017年學術文章 wetenschappelijk artikel scienca artikolo مقالة علمية نشرت في 22 ديسمبر 2017 naučni članak научна статия научни чланак наукова стаття, опублікована в грудні 2017 2017 nî lūn-bûn articolo scientifico artikull shkencor мақолаи илмӣ scientific article published on 22 December 2017
p:P577
wds:Q47561313-9F186444-1DF1-4013-9E6E-7189C0CAF52D
wdt:P577
2017-12-22T00:00:00Z
p:P407
wds:Q47561313-959B6942-A1A5-4D5A-A63D-9537ABFE4E6F
wdt:P407
wd:Q1860
p:P2860
wds:Q47561313-3EC645F8-04CD-42E6-820E-171555F2DDFE wds:Q47561313-4E73915A-421F-4D16-B377-E282266C7F15 wds:Q47561313-45B6BA7D-BA53-42E1-B0A6-31D69919FC1F wds:Q47561313-3135F6E3-75AE-4647-9FF6-87831EB4708F wds:Q47561313-30C40239-192C-494C-BD62-B7A6AF040F3A wds:Q47561313-5FF38C32-80D3-4E89-99AA-08C73380A9DD wds:Q47561313-5E0E41EA-EDC4-4710-979D-B40D8A2EC748 wds:Q47561313-679F3E59-3205-41FA-82B5-23E4CE68F91F wds:Q47561313-ECBBCA9B-EBCA-4995-9AE0-10A4CE1CEC80 wds:Q47561313-628577D3-FF1D-4106-BAEF-B8252901B333 wds:Q47561313-5996C776-C322-4188-B83B-42106FC5A4E0 wds:Q47561313-F44BE7EF-F34E-491B-8253-5E66B80AB311 wds:Q47561313-575021E0-2A58-491B-AC17-A305B73FDDA8 wds:Q47561313-5B6BA3BB-FDD9-4790-ABB8-6A1E87425402 wds:Q47561313-02C43602-F6CA-40B6-AB3F-884DED21048A wds:Q47561313-027F2CD8-CF41-4B13-87BC-F21DE419F2AC wds:Q47561313-0D6C22EF-5299-42F6-9CCD-1FCF76E16AD1 wds:Q47561313-0BB7F357-31A1-409D-B283-5BC8AC701502 wds:Q47561313-C4F346A5-8DE6-4F7D-9177-F914ECF46352 wds:Q47561313-1D84B765-8CBA-4F7C-B0AE-839C35359213 wds:Q47561313-BEFB4A93-F769-45B5-BA4D-346C64DB27E5 wds:Q47561313-1AB1A521-EE38-425E-818A-A4096FACCE04 wds:Q47561313-AAB37AE1-AAE3-4A4D-8666-2A83CE8D511B wds:Q47561313-25CB8944-F0CD-4233-9524-986D0B27BCBE wds:Q47561313-2233256A-32CC-49FB-BEA1-EF95B69A6555 wds:Q47561313-AF50C85B-B90E-4EE8-9D41-B2107886F76C wds:Q47561313-14881816-ACF8-4619-85DC-2CB97520C285 wds:Q47561313-AAE341BD-B49F-418C-AB72-CBECFC495BD0 wds:Q47561313-108AABBB-0F06-46B4-886C-A089D71FACE0 wds:Q47561313-1A625BE3-ED72-4024-8072-A8BB290AFECC wds:Q47561313-DD61078F-F322-4CB0-BD8E-DFCD22EA1549 wds:Q47561313-1A187457-90F7-476F-A4F4-22437F6C69C3 wds:Q47561313-D876189F-AD72-4915-A92F-F057D33ADC3F wds:Q47561313-E894F5E5-43BA-40C6-893E-8C0E5CDEFE89 wds:Q47561313-CA8CC968-9C9D-4033-B17E-4A80A104FFD4 wds:Q47561313-C5B41A87-1768-462E-8FB4-F7C82AC86D7F wds:Q47561313-D6DEB8DD-C4D8-4295-8186-F6C54A1DAC7A wds:Q47561313-CBF5FF08-71E9-4F38-A65F-550FD29A5BF3 wds:Q47561313-79236ED1-9DCA-41B5-804E-93B72D917BDB wds:Q47561313-7AFFFAB2-0C93-4209-AB7B-52EF56695B61 wds:Q47561313-7ABAFF4F-F0C4-4932-8936-A859195EA408 wds:Q47561313-71FB4110-92CD-4885-8FF9-1714B4270CA6 wds:Q47561313-6831E42D-9C13-4F71-8C02-0068624C9028 wds:Q47561313-7633E3AA-BEAC-4EA1-A75B-2BF99DF37096 wds:Q47561313-73872058-6B08-4535-85FB-13838ECBE46B wds:Q47561313-96DEC9B9-E80C-4303-9285-DB03DE849CF8 wds:Q47561313-9B9D0677-6C18-4353-8522-C353F16824DF wds:Q47561313-8E11E837-8F31-4AE6-BD7F-2402A29AD774 wds:Q47561313-837136C6-E612-4EEB-8FBB-112963570429 wds:Q47561313-9004A4A5-8DFE-4C48-9010-4A885E3DA1A9
wdt:P2860
wd:Q43001243 wd:Q38965567 wd:Q50584672 wd:Q27860719 wd:Q29620137 wd:Q35194406 wd:Q42267579 wd:Q40251971 wd:Q34320498 wd:Q40814311 wd:Q46790729 wd:Q41613250 wd:Q42211649 wd:Q34725795 wd:Q38635796 wd:Q42981494 wd:Q42225334 wd:Q36810865 wd:Q36590782 wd:Q40289398 wd:Q38669306 wd:Q27860901 wd:Q42211652 wd:Q41752261 wd:Q29619799 wd:Q42202640 wd:Q38976494 wd:Q40086984 wd:Q44579440 wd:Q37056536 wd:Q26769709 wd:Q29620617 wd:Q24683611 wd:Q35286136 wd:Q29619800 wd:Q43001248 wd:Q40098679 wd:Q38623932 wd:Q28181608 wd:Q29619763 wd:Q30245058 wd:Q38556915 wd:Q42251577 wd:Q24550676 wd:Q42223532 wd:Q34632295 wd:Q29547886 wd:Q34649453 wd:Q42980402 wd:Q38592257
p:P2093
wds:Q47561313-5ADA1888-021D-439C-A5D8-24531A6A7393 wds:Q47561313-F6114166-780E-42E3-81DA-8664346D8837
wdt:P2093
Onyema Ogbuagu Ashly Maughan
rdfs:label
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.
skos:prefLabel
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.
schema:name
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.
p:P1476
wds:Q47561313-308BBFC2-B3C3-42AD-AB87-5B0594FA0E4B
wdt:P1476
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.
p:P304
wds:Q47561313-95DCB51E-FEB3-4761-A34E-058377C5F821
wdt:P304
219-227
p:P31
wds:Q47561313-f89b78ca-9023-4f7d-9b23-92a4a62c67af wds:Q47561313-E99B741B-DA47-4081-87F8-4D9B31962904
wdt:P31
wd:Q13442814 wd:Q7318358
p:P921
wds:Q47561313-79B933AE-195E-47D0-B411-AADA339E18F8 wds:Q47561313-ED91A3FA-74C7-4135-95CD-DB02E6C97C75
wdt:P921
wd:Q708693 wd:Q7160835
p:P698
wds:Q47561313-2F364D3A-3B36-4C81-8BF9-5285E6CBE136
wdtn:P698
n12:29271660
wdt:P698
29271660
p:P1433
wds:Q47561313-35B85CF4-2B1C-405C-A6BB-B3017E91484D
wdt:P1433
wd:Q5421205
p:P433
wds:Q47561313-B29BC428-2F80-4412-95D7-BEEE622B033A
p:P478
wds:Q47561313-974E559D-65B6-4288-B090-2954F1B552C5
wdt:P433
2
wdt:P478
14
p:P356
wds:Q47561313-BD5A2FC6-4D89-441D-995F-C9D1950C5ACE
wdtn:P356
n9:17425255.2018.1421173
wdt:P356
10.1080/17425255.2018.1421173